Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
January 31, 2018
Arcturus Therapeutics Announces Extraordinary General Meeting of Shareholders
SAN DIEGO, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd., or Arcturus (ARCT), an RNA medicines company, today announced that it will hold an ...
January 31, 2018
Kiadis Pharma - Last Patient Dosed with ATIR101™ in the Phase II ‘008’ Clinical Trial
AMSTERDAM-DUIVENDRECHT, Netherlands--(BUSINESS WIRE)--Regulatory News: Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell therapy products ...
January 31, 2018
INNATE PHARMA : Prof. Jean-Yves Blay appointed to the Innate Pharma Supervisory Board
Marseille, France, January 31, 2018, 7:00 AM CET Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH) today announces that Prof. Jean-Yves Blay has ...
January 31, 2018
Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference
BOSTON, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), announced today that its President, Chief Operating Officer and Chief Medical Officer, Evan Loh, ...
January 31, 2018
Intec Pharma Names R. Michael Gendreau, M.D., Ph.D. as Chief Medical Officer
JERUSALEM, Jan. 31, 2018 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) (NTEC), a clinical stage biopharmaceutical company focused on developing pharmaceutical therapies based on its proprietary Accordion ...
January 31, 2018
Acer Therapeutics to Present at the LEERINK Partners 7th Annual Global Healthcare Conference
NEWTON, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for ...
January 31, 2018
Catalyst Biosciences to Present Multi-Dose Subcutaneous Data for CB 2679d in Individuals with Hemophilia B in an Oral Presentation at the 11th Annual Congress of EAHAD
SOUTH SAN FRANCISCO, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
January 31, 2018
Genkyotex Reports December 31, 2017 Cash Position and Provides Business Update
ARCHAMPS, France--(BUSINESS WIRE)--Regulatory News: Genkyotex (GKTX.PA) (GKTX.PA) (Euronext Paris & Brussels: FR00011790542 – GKTX), a biopharmaceutical company and the leader in NOX therapies, today reported cash, ...
January 31, 2018
Gemphire Announces Initiation of Phase 2a Clinical Trial of Gemcabene in Pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)
LIVONIA, Mich., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
January 31, 2018
Zogenix Completes Enrollment in Second ZX008 Phase 3 Clinical Trial in Dravet Syndrome
EMERYVILLE, Calif., Jan. 31, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) ...
January 31, 2018
AIT Therapeutics Announces Completion of the Agreement to License the Revolutionary Nitric Oxide (NO) Generator and Delivery System
NEW YORK, Jan. 31, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
January 30, 2018
Albireo Announces Closing of $74.8 Million Public Offering Including Exercise of Underwriters’ Option to Purchase Additional Shares
BOSTON, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, announced today ...
January 30, 2018
Sierra Oncology to Present at the DNA Damage Response Therapeutics Summit
VANCOUVER, Jan. 29, 2018 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) therapeutics for ...
January 30, 2018
CymaBay Announces Pricing of Public Offering of Common Stock
NEWARK, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic ...
January 30, 2018
BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada
RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) --BioDelivery Sciences International, Inc. (BDSI) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal film is now ...
January 29, 2018
ABIVAX Appoints Carol L. Brosgart, M.D. to its Board of Directors
PARIS, Jan. 29, 2018, 8 a.m. CET – ABIVAX (Euronext Paris: FR0012333284 – ABVX), a biotechnology company harnessing the immune system to develop a functional cure ...
January 29, 2018
Prometic's PBI-4050: Phase 3 Pivotal Clinical Trial Design For Idiopathic Pulmonary Fibrosis (IPF) Finalized
LAVAL, QC, Jan. 29, 2018 /PRNewswire/ - Prometic Life Sciences Inc. (PLI.TO) (PFSCF) ("Prometic") announces today the outcome of a successful clinical development Type C meeting with the US ...
January 29, 2018
Renevia® Data From the Successful Pivotal Trial to Be Presented at the IMCAS Conference
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a late-stage, clinical biotechnology company developing and commercializing products addressing degenerative diseases, today announced that detailed data from the ...
January 29, 2018
Aradigm Receives Complete Response Letter from the FDA for Linhaliq NDA
HAYWARD, Calif.--(BUSINESS WIRE)--Aradigm Corporation (ARDM) (the “Company”) today announces that it received a Complete Response Letter (CRL) from the US Food and Drug Administration (FDA) regarding ...
January 29, 2018
Pernix Announces Patent Litigation Settlement Agreement with Actavis Concerning Zohydro® ER
MORRISTOWN, N.J., Jan. 29, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, today announced that it has entered into a ...
Page 68 of 117